NANO MRNA Co.,Ltd.
4571.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥10,154,468 | ¥12,789,222 | ¥16,822,075 | ¥18,049,034 |
| - Cash | ¥1,707,452 | ¥2,077,635 | ¥2,811,624 | ¥3,545,000 |
| + Debt | ¥540,241 | ¥1,108,916 | ¥1,108,916 | ¥1,150,000 |
| Enterprise Value | ¥8,987,257 | ¥11,820,503 | ¥15,119,367 | ¥15,654,034 |
| Revenue | ¥108,516 | ¥135,508 | ¥202,189 | ¥264,032 |
| % Growth | -19.9% | -33% | -23.4% | – |
| Gross Profit | ¥78,166 | ¥110,956 | ¥159,599 | ¥222,741 |
| % Margin | 72% | 81.9% | 78.9% | 84.4% |
| EBITDA | -¥832,573 | -¥863,000 | -¥1,245,864 | -¥2,057,898 |
| % Margin | -767.2% | -636.9% | -616.2% | -779.4% |
| Net Income | -¥835,380 | -¥780,002 | -¥1,310,976 | -¥1,881,678 |
| % Margin | -769.8% | -575.6% | -648.4% | -712.7% |
| EPS Diluted | -11.85 | -11.1 | -18.7 | -26.9 |
| % Growth | -6.8% | 40.6% | 30.5% | – |
| Operating Cash Flow | -¥401,617 | -¥585,081 | -¥1,087,051 | -¥1,752,992 |
| Capital Expenditures | ¥401,617 | ¥0 | ¥0 | -¥6,215 |
| Free Cash Flow | ¥0 | -¥585,081 | -¥1,087,051 | -¥1,759,207 |